Seeded assembly in vitro does not replicate the structures of α‐synuclein filaments from multiple system atrophy

Sofia Lövestam, Manuel Schweighauser, Tomoyasu Matsubara, Shigeo Murayama, Taisuke Tomita, Takashi Ando, Kazuko Hasegawa, Mari Yoshida, Airi Tarutani, Masato Hasegawa, Michel Goedert, Sjors H. W. Scheres

TL;DR

This study investigates whether in vitro seeded assembly of recombinant α-synuclein can faithfully replicate the complex filament structures found in the brains of patients with Multiple System Atrophy (MSA). The findings reveal that seeded assemblies do not fully recapitulate the native MSA filament structures, suggesting that additional factors beyond the α-synuclein protein itself are crucial for the propagation of these pathological protein strains in vivo. This has significant implications for understanding the mechanisms behind neurodegenerative diseases like MSA.

What Problem Does This Paper Address?

Neurodegenerative diseases such as Parkinson's Disease, Dementia with Lewy Bodies (DLB), and Multiple System Atrophy (MSA) are characterized by the misfolding and aggregation of α-synuclein protein into filamentous structures. A key concept in understanding these diseases is "prion-like spreading," where these pathological protein aggregates, or "seeds," can template the misfolding of normal α-synuclein, leading to disease progression. Researchers have previously determined the atomic structures of α-synuclein filaments from MSA brains, revealing distinct "strains" with different conformations. However, a critical unanswered question is whether in vitro methods, specifically seeded assembly using recombinant α-synuclein and brain-derived seeds, can accurately reproduce these native, disease-specific filament structures. If in vitro methods fail to replicate these structures, it implies that other factors present in vivo are essential for the precise templating and propagation of these disease-associated protein strains. This paper aims to address this gap by directly comparing the structures of in vitro seeded α-synuclein filaments with those isolated from MSA patient brains.

Methods

The study employed cryo-electron microscopy (cryo-EM) as the primary technique to determine the high-resolution structures of α-synuclein filaments. Specifically, they used helical reconstruction methods, which are well-suited for analyzing the elongated, filamentous structures of amyloid aggregates.

The core experimental approach involved:

  • Seeded Assembly: Recombinant wild-type human α-synuclein was incubated with pre-existing α-synuclein filament preparations (seeds) extracted from the putamen of three different MSA patients. These seeds were characterized by varying ratios of two previously identified MSA filament types (Type I and Type II).
  • Cryo-EM Data Collection and Processing: Filaments were plunge-frozen onto grids and imaged using a high-resolution cryo-EM microscope. Sophisticated image processing pipelines, including motion correction, CTF estimation, particle picking, 2D classification, and 3D helical reconstruction, were used to generate 3D density maps of the assembled filaments.
  • Atomic Model Building: Atomic models of the filament structures were built de novo into the cryo-EM density maps using crystallographic software and refined against the experimental data.

The study also utilized negative-stain electron microscopy for initial visualization and characterization of filaments, and thioflavin T fluorescence to monitor the kinetics of in vitro aggregation.

Datasets

The primary "dataset" in this study consists of α-synuclein filament preparations extracted directly from the putamen of three human individuals diagnosed with Multiple System Atrophy (MSA). These patient-derived filaments served as the "seeds" for the in vitro assembly experiments. The study also utilized recombinant wild-type human α-synuclein as the monomeric protein to be assembled.

No new benchmarks were introduced. The study focuses on comparing the structures of in vitro assembled filaments to those previously characterized from human brain tissue.

Key Insights and Ideas

  • The "Prion-like" Mechanism is More Complex Than Simple Templating: The central finding is that in vitro seeded assembly of recombinant α-synuclein, even with brain-derived seeds, does not perfectly replicate the native filament structures. This suggests that the propagation of α-synuclein strains in vivo likely involves more than just the α-synuclein protein itself.
  • The Importance of Cofactors/Cellular Environment: The discrepancy between in vitro and in vivo structures strongly implies that other cellular components (e.g., lipids, nucleic acids, other proteins) or post-translational modifications present in the brain environment play a critical role in dictating the precise conformation and propagation of α-synuclein strains.
  • Structural Diversity of α-Synuclein Filaments: The study further elaborates on the structural diversity of α-synuclein filaments, identifying distinct types (Type 1, Type 2, and Type 3) formed under different seeding conditions. This highlights the inherent plasticity of α-synuclein assembly.
  • Implications for Disease Strain Identification: The findings raise caution for interpreting results from in vitro seeded aggregation assays used to discriminate between disease strains (e.g., PD vs. MSA). While these assays can be informative, they may not fully capture the structural nuances of in vivo pathological strains.

Key Results

  • Differential Filament Formation: When seeds from MSA cases 1 and 2 (containing a mixture of Type I and Type II filaments) were used, the in vitro assembly primarily produced Type 1 and Type 2 filaments. However, the structures of these seeded filaments differed from the original MSA seeds.
  • Type 3 Filaments from Specific Seeds: Seeds from MSA case 5, which predominantly contained Type II filaments, almost exclusively resulted in the formation of a distinct Type 3 filament structure in vitro. This Type 3 filament structure was found to be nearly identical to a previously characterized protofilament (IIB2) from MSA brains, suggesting a better, though not perfect, replication in this specific instance.
  • Structural Differences: Detailed cryo-EM structural analysis revealed that the seeded Type 1 and Type 2 filaments, while sharing some similarities with MSA filaments, exhibited differences in protofilament folds, inter-protofilament packing, and the presence of specific salt bridges.
  • Absence of Native Cofactors: The study speculates that the observed differences might be due to the absence of negatively charged, non-proteinaceous molecules that were previously identified at the inter-protofilament interfaces of native MSA filaments.

Limitations and Future Work

  • Limitations:
    • The study acknowledges that the in vitro seeded assemblies do not fully replicate the structures of the native MSA seeds, indicating that additional factors are at play in vivo.
  • The exact nature of these missing factors remains unknown.
  • While Type 3 filaments showed better replication, subtle differences might still exist.
  • Future Work:
    • The authors emphasize the need to identify the additional factors that govern the faithful replication of conformational prion strains. This is crucial for a comprehensive understanding of disease propagation.
  • Investigating whether seeds from Parkinson's disease brains yield different structures when used for in vitro seeded assembly would be a valuable next step.
  • Exploring the role of specific post-translational modifications and cellular cofactors (like lipids, DNA, RNA, iron, and phosphate) in influencing α-synuclein filament structure and propagation is highlighted as an important avenue for future research.

Summary updated

Abstract

The propagation of conformational strains by templated seeding is central to the prion concept. Seeded assembly of α-synuclein into filaments is believed to underlie the prion-like spreading of protein inclusions in a number of human neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). We previously determined the atomic structures of α-synuclein filaments from the putamen of five individuals with MSA. Here, we used filament preparations from three of these brains for the in vitro seeded assembly of recombinant human α-synuclein. We find that the structures of the seeded assemblies differ from those of the seeds, suggesting that additional, as yet unknown, factors play a role in the propagation of the seeds. Identification of these factors will be essential for understanding the prion-like spreading of α-synuclein proteinopathies.
BibTeX
@inproceedings{lovestam2021seeded,
  author = {Sofia Lövestam and Manuel Schweighauser and Tomoyasu Matsubara and Shigeo Murayama and Taisuke Tomita and Takashi Ando and Kazuko Hasegawa and Mari Yoshida and Airi Tarutani and Masato Hasegawa and Michel Goedert and Sjors H. W. Scheres},
  title = {{Seeded assembly <i>in vitro</i> does not replicate the structures of α‐synuclein filaments from multiple system atrophy}},
  booktitle = {FEBS},
  year = {2021},
  doi = {10.1002/2211-5463.13110},
}
Figure